Spheryx Announces Two Presentations at PittCon, the World's Largest Conference for Laboratory Science

Spheryx will be making two presentations at PittCon in Atlanta, GA on Monday and Tuesday, March 6 and 7 on their patented Total Holographic Characterization™ and its applications.

Mar 07, 2016, 08:13 ET from Spheryx, Inc.

NEW YORK, March 7, 2016 /PRNewswire/ -- Spheryx, Inc. will present at the PittCon 2016 Conference and Expo, the world's largest annual premier conference and exposition on laboratory science.  The presentations will cover Spheryx's patented Total Holographic Characterization™ and its applications to protein aggregation in biologics, quality assurance of semiconductor polishing slurries, wastewater monitoring, and consumer products characterization.  Dr. David Ruffner, Director of Analytical Sciences and Research Scientist, will make a presentation at 1 pm on Tuesday, March 7, and Jaroslaw Blusewicz, Scientist, will make a presentation on Monday, March 6 at 1 pm.  Both presentations will take place on the Exposition Floor of the Georgia World Congress Center, Atlanta, GA.

About Spheryx, Inc.
Spheryx, Inc. is a privately held analytical services and instruments company providing Total Holographic CharacterizationTM of colloidal materials.  Spheryx's breakthrough proprietary technology uses holographic video microscopy to characterize each particle in colloidal dispersions and multi-component colloidal mixtures, thereby offering unprecedented insights into these materials' characteristics.  Applications include research and development, quality assurance and manufacturing process control across a broad spectrum of industries, where characterization of colloids can enhance innovation, improve safety and reduce costs.  For more information please visit the company's website at http://www.spheryx.solutions/

Note: This news release contains forward-looking statements regarding future events.  These statements are just predictions and are subject to risks and uncertainties that could cause the actual events or result to differ materially.  These risks and uncertainties include, among others: the results, timing and costs of our studies; our ability to obtain future funding on acceptable terms; the possible impairment of, or inability to obtain intellectual property rights; and innovation by our competitors.

Contact:
Laura Philips, CEO
lphilips@spheryx.solutions 
607-738-0100

Logo - http://photos.prnewswire.com/prnh/20160208/330974LOGO

SOURCE Spheryx, Inc.



RELATED LINKS

http://www.spheryx.solutions